Student.Heart Failure - Tagged

Chapter 34: Heart Failure

Heart Failure Overview

• Definition: Complex clinical syndrome resulting in insufficient blood supply/oxygen to tissues and organs.

• Cardiac Output: Decreased cardiac output leads to decreased tissue perfusion.

• Ejection Fraction (EF): Measures the amount of blood pumped out of the left ventricle per heartbeat.

Types of Heart Failure

• Heart Failure with Reduced Ejection Fraction (HFrEF):

  • Defect in ventricular systolic function (LV contraction).

• Heart Failure with Preserved Ejection Fraction (HFpEF):

  • Defect in ventricular diastolic function (filling).

Risk Factors

• Primary Risk Factors:

  • Hypertension: Modifiable risk factor; aggressive treatment can reduce incidence of HF by 50%.

  • Coronary Artery Disease (CAD): Co-morbidities contributing to development of HF.

Etiology of Heart Failure

• Primary Causes: Conditions directly damaging the heart.

• Precipitating Causes: Conditions increasing workload of the heart.

Classification of Heart Failure

• Left-sided Heart Failure:

  • Most common form; inability to adequately empty or fill the left ventricle.

  • Classified as HFrEF (systolic) or HFpEF (diastolic) or a combination.

Pathophysiology

• HF with Reduced EF (HFrEF):

  • Caused by decreased LV ejection fraction due to impaired contractile function, increased afterload, or mechanical abnormalities.

• HF with Preserved EF (HFpEF):

  • Caused by inability of the ventricles to relax and fill, primarily due to hypertension.

Left-Sided Heart Failure

• Consequences:

  • Blood backs up into the left atrium, leading to increased pulmonary hydrostatic pressure, fluid leakage into the pulmonary capillary bed, and pulmonary congestion/edema.

Right-Sided Heart Failure

• Mechanisms:

  • Right ventricle does not pump effectively, causing fluid backup in the venous system and movement into tissues/organs.

  • Most commonly caused by left-sided HF, RV infarction, pulmonary embolism, cor pulmonale.

Biventricular Failure

• Description:

  • Inability of both ventricles to pump effectively, leading to fluid build-up and decreased perfusion to vital organs.

Compensatory Mechanisms

• Renin-Angiotensin-Aldosterone System (RAAS):

  • Regulatory system aiming to augment preload and contractility, promoting sodium and water retention.

• Neurohormonal Response:

  • Decreased cardiac output leads to decreased renal perfusion, renin release, and subsequent vasoconstriction and fluid retention.

• Sympathetic Nervous System Activation:

  • Baroreceptors sense low arterial pressure, leading to catecholamine release and increased heart rate/contractility.

Compensatory Mechanisms in Heart Failure

• Dilation:

  • Enlargement of heart chambers due to prolonged pressure elevation, initially effective but can lead to decreased cardiac output.

• Hypertrophy:

  • Adaptive increase in heart muscle mass; eventually leads to poor contractility and increased oxygen demand.

• Remodeling:

  • Continuous neurohormonal activation causes changes leading to life-threatening outcomes.

Counterregulatory Mechanisms

• Natriuretic Peptides (ANP & BNP):

  • Released in response to increased blood volume, promoting diuresis, vasodilation, and counteracting harmful effects of other mechanisms.

• Nitric Oxide & Prostaglandin:

  • Promote vasodilation and decreased afterload in response to compensatory mechanisms.

Acute Decompensated Heart Failure (ADHF)

• Clinical Manifestations:

  • Symptoms include tachypnea, shortness of breath, pulmonary congestion, and interstitial edema.

  • Can manifest as pulmonary edema, primarily associated with left-sided HF.

Classification of Patient Status in ADHF

• Categories:

  • Dry-warm, dry-cold, wet-warm (most common), wet-cold.

Chronic Heart Failure

• Clinical Manifestations:

  • Symptoms include fatigue, dyspnea, orthopnea, cough, tachycardia, and edema.

  • May include skin changes, neurological manifestations, and changes in mental status.

Heart Failure Complications

• Common Complications:

  • Pleural effusion, dysrhythmias, cardiomegaly, and cardiorenal syndrome.

Diagnostic Studies

• Echocardiogram:

  • Assess LVEF, heart valves, presence of effusion or thrombus.

• Other Tests:

  • Includes ECG, chest x-ray, BNP levels.

Interprofessional Care for ADHF

• Monitoring and Assessment:

  • Continuous monitoring of vital signs, oxygen saturation, and urine output.

  • Strategies include high Fowler’s position and supplemental oxygen.

• Extracorporeal Therapy:

  • Ultrafiltration for volume overload and mechanical assist devices for deteriorating HF.

Drug Therapy for ADHF

• Diuretics:

  • Loop diuretics (Furosemide) to decrease volume overload.

• Vasodilators:

  • IV nitroglycerin and nitroprusside to reduce preload and afterload.

• Positive Inotropes:

  • β-agonists, digitalis for improving contractility.

Chronic Heart Failure Interprofessional Care

• Goals:

  • Treat underlying causes, maximize cardiac output, and improve quality of life.

• Oxygen Therapy and Physical Rest:

  • Oxygen to relieve symptoms and support physical and emotional rest as needed.

Chronic Heart Failure Drug Therapy

• RAAS Inhibitors:

  • ACE inhibitors, ARBs, and aldosterone antagonists are key treatments.

• Beta Blockers:

  • Monitor potassium levels; manage hypertension and heart failure.

Patient Teaching

• Signs of Worsening HF:

  • Important to recognize early symptoms and manage lifestyle accordingly.

• Exercise and Nutrition:

  • Importance of individualized exercise plans and dietary guidelines, including sodium restrictions.

Mechanical Circulatory Support

• Therapeutic Options:

  • Include mechanical devices for advanced heart failure treatment, such as LVAD and palliative care.

Heart Transplantation

• Criteria and Process:

  • Gold standard for end-stage HF; candidates undergo thorough evaluations.

  • Post-transplant care focuses on monitoring and managing complications like rejection and infection.

Chapter 34: Heart Failure

Heart Failure Overview

Definition: Heart failure (HF) is a complex clinical syndrome resulting in an inadequate blood supply and oxygen delivery to tissues and organs, often due to the heart’s inability to pump effectively. This condition can lead to various systemic complications and increased morbidity and mortality rates.

Cardiac Output: Cardiac output, the volume of blood the heart pumps per minute, is significantly decreased in heart failure, leading to reduced perfusion of tissues and organs, impacting their function.

Ejection Fraction (EF): Ejection fraction is a critical measure in heart failure management, representing the percentage of blood pumped out of the left ventricle with each heartbeat. It helps classify heart failure into two primary categories.

Types of Heart Failure

1. Heart Failure with Reduced Ejection Fraction (HFrEF):

   • Characterized by a defect in ventricular systolic function, which refers to the heart's ability to contract and pump blood.

   • Typically indicates an EF of less than 40%.

2. Heart Failure with Preserved Ejection Fraction (HFpEF):

   • Defined by a defect in the ability of the ventricle to relax and fill adequately, often resulting in elevated pressures in the heart.

   • Patients usually present with an EF of 50% or greater, highlighting issues with diastolic function rather than systolic.

Risk Factors

Primary Risk Factors:

• Hypertension: A significant and modifiable risk factor for heart failure, aggressive management can reduce the incidence of HF by as much as 50%.

• Coronary Artery Disease (CAD): A common co-morbidity that plays a crucial role in the development of heart failure due to reduced blood flow to the heart muscle.

Etiology of Heart Failure

• Primary Causes: Conditions that directly damage the heart muscle, leading to heart failure include ischemic heart disease, valvular heart disease, and myocarditis.

• Precipitating Causes: Conditions that increase the workload of the heart, such as severe anemia, infection, and hyperthyroidism, can precipitate heart failure symptoms in patients with underlying heart issues.

Classification of Heart Failure

Left-sided Heart Failure:

• The most prevalent form; characterized by the inability of the left ventricle to adequately empty or fill, leading to reduced cardiac output.

• This type is further categorized as HFrEF or HFpEF, depending on the systolic or diastolic dysfunction exhibited.

Pathophysiology

HF with Reduced EF (HFrEF):

• Primarily caused by decreased left ventricular ejection fraction due to impaired contractile function, which may arise from conditions such as myocardial infarction, increased afterload due to hypertension, or structural abnormalities of the heart.

HF with Preserved EF (HFpEF):

• Primarily caused by an impairment in the ability of the ventricles to relax and fill, largely associated with chronic hypertension and comorbid conditions such as obesity or diabetes mellitus.

Left-Sided Heart Failure

Consequences:

• Blood backs up into the left atrium, which causes increased pulmonary hydrostatic pressure that leads to fluid leakage into the pulmonary capillary bed, resulting in pulmonary congestion and edema. Symptoms include dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.

Right-Sided Heart Failure

Mechanisms:

• The right ventricle fails to pump blood effectively, resulting in fluid accumulation in the venous system and peripheral tissues. This failure can be due to left-sided heart failure, right ventricular infarction, pulmonary embolism, and cor pulmonale, leading to symptoms such as peripheral edema and ascites.

Biventricular Failure

Description:

• A condition characterized by the inability of both ventricles to pump effectively, leading to fluid buildup in the lungs and systemic circulation, causing widespread cardiovascular compromise and impaired organ perfusion.

Compensatory Mechanisms

• Renin-Angiotensin-Aldosterone System (RAAS): A crucial hormonal regulatory system activated in heart failure, aiming to augment preload and contractility of the heart, promoting sodium and water retention.

• Neurohormonal Response: Activation leads to decreased renal perfusion, stimulating renin release, which in turn contributes to systemic vasoconstriction and fluid retention, worsening heart failure symptoms.

• Sympathetic Nervous System Activation: Baroreceptors respond to low arterial pressure, releasing catecholamines, which increase heart rate and contractility, initially compensating for decreased cardiac output but can further strain the heart over time.

Compensatory Mechanisms in Heart Failure

• Dilation: Enlargement of heart chambers due to prolonged pressure elevation; initially compensatory but can progress to reduced cardiac output.

• Hypertrophy: Adaptive increase in heart muscle mass due to increased workload, but can lead to decreased contractility and heightened oxygen demand over time.

• Remodeling: Chronic neurohormonal activation can induce structural changes in the heart's architecture, leading to adverse outcomes such as increased morbidity and mortality.

Counterregulatory Mechanisms

• Natriuretic Peptides (ANP & BNP): Released in response to increased blood volume, these peptides promote diuresis, vasodilation, and oppose the harmful effects of neurohormonal activation.

• Nitric Oxide & Prostaglandin: Play roles in vasodilation and the decrease of afterload as a counterbalance to compensatory mechanisms during heart failure.

Acute Decompensated Heart Failure (ADHF)

Clinical Manifestations:

• Symptoms include tachypnea, shortness of breath, and significant pulmonary congestion, indicating possible acute pulmonary edema, particularly associated with left-sided heart failure.

Classification of Patient Status in ADHF

• Categories include dry-warm, dry-cold, wet-warm (most prevalent in presentations), and wet-cold status.

Chronic Heart Failure

Clinical Manifestations:

• Symptoms are diverse, including fatigue, persistent dyspnea, orthopnea, cough, tachycardia, and edema. Patients might exhibit skin changes, neurological manifestations, and altered mental status due to inadequate cerebral perfusion.

Heart Failure Complications

Common Complications:

• Include pleural effusion, various dysrhythmias, cardiomegaly, and cardiorenal syndrome, with each complication contributing to the overall burden of the disease.

Diagnostic Studies

• Echocardiogram: Essential for assessing left ventricular ejection fraction (LVEF), evaluating heart valves, and identifying the presence of effusion or thrombus.

• Other Tests: Complementary tests like ECG, chest X-ray, and measurement of B-type natriuretic peptide (BNP) levels are crucial in diagnosing heart failure and assessing severity.

Interprofessional Care for ADHF

Monitoring and Assessment:

• Continuous monitoring of vital signs, oxygen saturation levels, and urine output are key metrics in managing acute decompensated heart failure effectively. Strategies include positioning patients in high Fowler’s position and providing supplemental oxygen for breath support.

• Extracorporeal Therapy: Such as ultrafiltration, may be employed for patients with significant volume overload; mechanical assist devices might be indicated for advanced heart failure cases.

Drug Therapy for ADHF

• Diuretics: Loop diuretics, such as Furosemide, are commonly administered to alleviate volume overload and resultant symptoms.

• Vasodilators: Intravenous medications like nitroglycerin and nitroprusside help in reducing preload and afterload, enhancing hemodynamic parameters in patients.

• Positive Inotropes: Such as β-agonists and digitalis, improve contractility of the heart, particularly in severe heart failure scenarios.

Chronic Heart Failure Interprofessional Care

Goals:

• Focused on treating underlying causes, maximizing cardiac output, and enhancing patients’ quality of life through comprehensive management strategies.

Oxygen Therapy and Physical Rest:

• Use of supplemental oxygen therapy is crucial to relieve symptoms, while ensuring adequate physical and emotional rest periods for affected patients.

Chronic Heart Failure Drug Therapy

• RAAS Inhibitors: ACE inhibitors, ARBs, and aldosterone antagonists form the cornerstone of treatment for heart failure, significantly improving survival.

• Beta Blockers: Important for managing heart failure by monitoring potassium levels and effectively controlling blood pressure.

Patient Teaching

Signs of Worsening HF:

• Educating patients about early symptoms is critical for prompt management and lifestyle adjustments to mitigate deterioration.

Exercise and Nutrition:

• Emphasis on individualized tailored exercise plans alongside dietary education, including sodium restrictions to support better clinical outcomes.

Mechanical Circulatory Support

Therapeutic Options:

• Devices for advanced heart failure management include Left Ventricular Assist Devices (LVAD) and palliative care measures to enhance patient comfort.

Heart Transplantation

Criteria and Process:

• Considered the gold standard for end-stage heart failure, candidates must undergo extensive evaluations to ensure appropriateness for the transplant procedure. Post-transplant care involves vigilant monitoring for complications such as rejection and infection management.